UK markets closed

Abeona Therapeutics Inc. (0H7R.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
3.2600+0.0594 (+1.86%)
At close: 05:29PM BST
Full screen
Previous close3.2006
Open3.1200
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's range3.1200 - 3.2600
52-week range2.3501 - 8.8000
Volume4,315
Avg. volume1,007
Market cap910,749
Beta (5Y monthly)1.48
PE ratio (TTM)N/A
EPS (TTM)-0.8080
Earnings date09 May 2024 - 13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Abeona Therapeutics Provides Regulatory Update on Pz-cel

    Receives FDA Complete Response Letter (CRL) based on need for additional CMC information CRL did not identify deficiencies related to clinical efficacy or clinical safety data in BLA, and no new clinical studies requested by FDA to support approval Anticipates completing and submitting requested CMC information in 3Q 2024 Conference call and webcast on Tuesday, April 23, 2024 at 8:30 a.m. ET to provide details on the requested CMC information CLEVELAND, April 22, 2024 (GLOBE NEWSWIRE) -- Abeona

  • GlobeNewswire

    Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    CLEVELAND, April 01, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). On March 31, 2024, the Compensation Committee of Abeona’s Board of Directors granted restricted stock equity awards as a material inducement to employment to seven individuals hired by Abeona, which equity awards relate to, in the

  • Simply Wall St.

    Here's Why We're Not Too Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Situation

    We can readily understand why investors are attracted to unprofitable companies. By way of example, Abeona Therapeutics...